AI assistant
Sending…
Ilirija d.d. — Interim / Quarterly Report 2017
Apr 28, 2017
2092_10-q_2017-04-28_85847710-32cc-4b54-b8f1-fa7870cc8cae.pdf
Interim / Quarterly Report
Open in viewerOpens in your device viewer
| Annex 1. Reporting period |
01.01. | 2017 | do | 31.03.2017. | |||
|---|---|---|---|---|---|---|---|
| Quarterly financial report TFI-POD | |||||||
| Tax number (MB): | 03311953 | ||||||
| Company registration number (MBS): |
060032302 | ||||||
| Personal identification number (OIB): |
05951496767 | ||||||
| Issuing company: ILIRIJA d.d. | |||||||
| Postal code and place | 23210 | BIOGRAD NA MORU | |||||
| Street and house number: TINA UJEVIĆA 7 | |||||||
| E-mail address: [email protected] | |||||||
| Internet address www.ilirijabiograd.com | |||||||
| unicipality/city code and name | 22 | BIOGRAD NA MORU | |||||
| County code and name | 13 | ZADARSKA | Number of employees: | 221 | |||
| Consolidated report: | NE | (period end) NKD code: |
55100 | ||||
| Companies of the consolidation subject (according to IFRS): | Seat: | MB: | |||||
| Bookkeeping service: | |||||||
| Contact person: | STRPIĆ ZORKA | ||||||
| Telephone: 023/383178 | (only surname and name) | Telefaks: | 023/384564 | ||||
| E-mail address: [email protected] | |||||||
| Family name and name: RAŽNJEVIĆ GORAN | (person authorized to represent the company) | ||||||
| Documents disclosed: and notes to financial statements); 2. Management Interim Report; 3. Declaration of the persons responsible for preparing the issuer's statements; |
1. Financial statements (Balance Sheet, Income Statement, Cash Flow Statement, Statement of Changes in Equity | ||||||
| L.S. | (signature of the person authorized to represent the company) |
Balance Sheet
as of 31/03/2017
| Company: ILIRIJA d.d. BIOGRAD NA MORU | |||
|---|---|---|---|
| Position | AOP | Previous | Current |
| period | period | ||
| 1 | 2 | 3 | 4 |
| A) RECEIVABELS FOR SUBSCRIBED NOT PAID CAPITAL | 001 | ||
| B) NON-CURRENT ASSETS (003+010+020+029+033) | 002 | 304.467.002 | 407.395.772 |
| I. INTANGIBLE ASSETS (004 to 009) | 003 | 499.332 | 336.452 |
| 1. Expenditure for development | 004 | ||
| 2. Concessions, patents, licenses, trademarks, service marks, software and other rights | 005 | ||
| 3. Goodwill | 006 | ||
| 4. Advances for purchase of intangible assets | 007 | ||
| 5. Intangible assets in progress | 008 | ||
| 6. Other intangible assets | 009 | 499.332 | 336.452 |
| II. PROPERTY, PLANT AND EQUIPMENT (011 to 019) | 010 | 303.927.670 | 407.019.320 |
| 1. Land | 011 | 42.340.227 | 42.340.227 |
| 2. Buildings | 012 | 223.266.279 | 232.347.442 |
| 3. Plant and equipement | |||
| 013 | 31.493.546 | 42.304.303 | |
| 4. Tools, working inventory and transportation assets | 014 | ||
| 5. Biological assets | 015 | ||
| 6. Advances for purchase of tangible assets | 016 | 451.889 | 1.239.522 |
| 7. Tangible assets in progress | 017 | 6.375.729 | 9.110.601 |
| 8. Other tangible assets | 018 | ||
| 9. Investment in real-estate | 019 | 79.677.225 | |
| III. NON-CURRENT FINANCIAL ASSETS (021 to 028) | 020 | 40.000 | 40.000 |
| 1. Share in related parties | 021 | 40.000 | 40.000 |
| 2. Loans to related parties | 022 | ||
| 3. Participating interests (shares) | 023 | ||
| 4. Loans to companies with participating interest | 024 | ||
| 5. Investments in securities | 025 | ||
| 6. Loans, deposits, etc. | 026 | ||
| 7. Other non-current financial assets | 027 | ||
| 8. Equity-accounted investments | |||
| 028 | |||
| IV. RECEIVABLES (030 to 032) | 029 | 0 | 0 |
| 1. Receivables from related parties | 030 | ||
| 2. Receivables arising from sales on credit | 031 | ||
| 3. Other receivables | 032 | ||
| V. DEFERRED TAX ASSET | 033 | ||
| C) CURRENT ASSETS (035+043+050+058) | 034 | 13.525.638 | 12.412.507 |
| I. INVENTORIES (036 to 042) | 035 | 2.107.739 | 2.358.997 |
| 1. Raw materials and supplies | 036 | 2.107.739 | 2.358.997 |
| 2. Production in progress | 037 | ||
| 3. Finished products | 038 | ||
| 4. Merchandise | 039 | ||
| 5. Advances for inventories | 040 | ||
| 6. Long term assets held for sale | 041 | ||
| 7. Biological assets | 042 | ||
| II. RECEIVABLES (044 to 049) | 043 | 6.206.221 | 6.543.758 |
| 1. Receivables from related parties | 044 | ||
| 2. Receivables from end-customers | 045 | 5.185.736 | 5.292.150 |
| 3. Receivables from participating parties | 046 | ||
| 4. Receivables from employees and members of the company | 047 | 618.899 | 826.678 |
| 5. Receivables from government and other institutions | 048 | 401.586 | 330.912 |
| 6. Other receivables | 049 | 94.018 | |
| III. CURRENT FINANCIAL ASSETS (051 to 057) | 050 | 5.033.986 | 2.434.811 |
| 1. Share in related parties | 051 | ||
| 2. Loans to related parties | 052 | ||
| 3. Participating interests (shares) | 053 | ||
| 4. Loans to companies with participating interest | |||
| 5. Investments in securities | 054 | ||
| 055 | |||
| 6. Loans, deposits, etc. | 056 | 5.033.986 | 2.434.811 |
| 7. Other financial assets | 057 | ||
| IV. CASH AND CASH EQUIVALENTS | 058 | 177.692 | 1.074.941 |
| D) PREPAYMENTS AND ACCRUED INCOME | 059 | 1.157.204 | |
| E) TOTAL ASSETS (001+002+034+059) | 060 | 319.149.844 | 419.808.279 |
| F) OFF BALANCE SHEET ITEMS | 061 |
| EQUITY AND LIABILITIES | |||
|---|---|---|---|
| A) ISSUED CAPITAL AND RESERVES (063+064+065+071+072+075+078) | 062 | 219.010.701 | 278.359.544 |
| I. SUBSCRIBED SHARE CAPITAL | 063 | 150.857.300 | 174.977.880 |
| II. CAPITAL RESERVES | 064 | 8.921.539 | 26.723.874 |
| III.RESERVES FROM PROFIT (066+067-068+069+070) | 065 | 21.693.815 | 23.435.964 |
| 1. Legal reserves | 066 | 7.610.344 | 9.477.986 |
| 2. Reserve for own shares | 067 | 6.975.716 | 6.975.716 |
| 3. Treasury shares and shares (deductible items) | 068 | 414.924 | 540.417 |
| 4. Statutory reserves | 069 | ||
| 5. Other reserves | 070 | 7.522.679 | 7.522.679 |
| IV. REVALUATION RESERVES | 071 | ||
| V. RETAINED EARNINGS OR LOSS CARRIED FORWARD (073-074) | 072 | 34.903.514 | 50.546.190 |
| 1. Retained earnings | 073 | 34.903.514 | 50.546.190 |
| 2. Loss carried forward | 074 | ||
| VI. NET PROFIT OR LOSS FOR THE PERIOD (076-077) | 075 | 2.634.533 | 2.675.636 |
| 1. Net profit for the period | 076 | 2.634.533 | 2.675.636 |
| 2. Net loss for the period | 077 | ||
| VII. MINORITY INTEREST | 078 | ||
| B) PROVISIONS (080 to 082) | 079 | 0 | 0 |
| 1. Provisions for pensions, severance pay and similar liabilities | 080 | ||
| 2. Provisions for tax liabilities | 081 | ||
| 3. Other provisions | 082 | ||
| C) NON-CURRENT LIABILITIES (084 to 092) | 083 | 58.253.754 | 109.846.075 |
| 1. Liabilites to related parties | 084 | ||
| 2. Liabilities for loans, deposits, etc. | 085 | ||
| 3. Liabilities to banks and other financial institutions | 58.253.754 | 109.846.075 | |
| 4. Liabilities for advances | 086 | ||
| 5. Trade payables | 087 | ||
| 6. Commitments on securities | 088 | ||
| 7. Liabilities to companies with participating interest | 089 | ||
| 8. Other non-current liabilities | 090 | ||
| 9. Deferred tax liabilities | 091 | ||
| D) CURRENT LIABILITIES (094 to 105) | 092 | ||
| 1. Liabilites to related parties | 093 | 35.794.491 | 26.132.786 |
| 2. Liabilities for loans, deposits, etc. | 094 | ||
| 3. Liabilities to banks and other financial institutions | 095 | 8.662.827 | 11.982.449 |
| 4. Liabilities for advances | 096 | ||
| 5. Trade payables | 097 | 12.239.609 | 9.038.461 |
| 6. Commitments on securities | 098 | 7.100.000 | 1.500.000 |
| 7. Liabilities to companies with participating interest | 099 | ||
| 8. Liabilities to emloyees | 100 | 1.054.967 | 1.256.163 |
| 9. Taxes, contributions and similar liabilities | 101 | 6.205.222 | 1.361.294 |
| 10. Liabilities arising from share in the result | 102 | ||
| 11. Liabilities arising from non-current assets held for sale | 103 | ||
| 104 | |||
| 12. Other current liabilities | 105 | 531.866 | 994.419 |
| E) ACCRUED EXPENSES AND DEFERRED INCOME | 106 | 6.090.898 | 5.469.874 |
| F) TOTAL EQUITY AND LIABILITIES (062+079+083+093+106) | 107 | 319.149.844 | 419.808.279 |
| G) OFF BALANCE SHEET ITEMS | 108 | ||
| ADDITION TO BALANCE SHEET (only for consolidated financial statements) | |||
| ISSUED CAPITAL AND RESERVES | |||
| 1. Attributable to majority owners | 109 | ||
| 2. Attributable to minority interest | 110 |
Income statement period 01/01/2017 to 31/03/2017
| Company: ILIRIJA d.d. BIOGRAD NA MORU | |||
|---|---|---|---|
| --------------------------------------- | -- | -- | -- |
| Position | AOP | Previous period | Current period | ||
|---|---|---|---|---|---|
| Cummulative | Quarter | Cummulative | Quarter | ||
| 1 | 2 | 3 | 4 | 5 | 6 |
| I. OPERATING INCOME (112 to 113) | 111 | 18.265.476 | 18.265.476 | 20.642.373 | 20.642.373 |
| 1. Sales revenues | 112 | 17.560.710 | 17.560.710 | 20.565.717 | 20.565.717 |
| 2. Other operating revenues | 113 | 704.766 | 704.766 | 76.656 | 76.656 |
| II. OPERATING COSTS (115+116+120+124+125+126+129+130) | 114 | 14.813.182 | 14.813.182 | 16.869.128 | 16.869.128 |
| 1. Change in inventories of work in progress | 115 | ||||
| 2. Material expenses (117 to 119) | 116 | 4.570.802 | 4.570.802 | 5.156.741 | 5.156.741 |
| a) Costs of raw materials | 117 | 1.641.931 | 1.641.931 | 2.072.545 | 2.072.545 |
| b) Cost of goods sold | 118 | ||||
| c) Other material expenses | 119 | 2.928.871 | 2.928.871 | 3.084.196 | 3.084.196 |
| 3. Employee benefits expenses (121 to 123) | 120 | 5.362.546 | 5.362.546 | 6.131.313 | 6.131.313 |
| a) Net salaries | 121 | 3.146.077 | 3.146.077 | 3.689.787 | 3.689.787 |
| b) Tax and contributions from salary expenses | 122 | 1.429.474 | 1.429.474 | 1.541.701 | 1.541.701 |
| c) Contributions on salary | 123 | 786.995 | 786.995 | 899.825 | 899.825 |
| 4. Depreciation and amortisation | 124 | 2.056.495 | 2.056.495 | 2.551.212 | 2.551.212 |
| 5. Other expenses | 125 | 2.653.411 | 2.653.411 | 2.911.900 | 2.911.900 |
| 6. Write down of assets (127+128) | 126 | 0 | 0 | 0 | 0 |
| a) non-current assets (except financial assets) | 127 | ||||
| b) current assets (except financial assets) | 128 | ||||
| 7. Provisions | 129 | ||||
| 8. Other operating costs | 130 | 169.928 | 169.928 | 117.962 | 117.962 |
| III. FINANCIAL INCOME (132 to 136) | 131 | 30.690 | 30.690 | 23.419 | 23.419 |
| 1. Interest, foreign exchange differences, dividens and similar income from related parties | 132 | 30.690 | 30.690 | 23.419 | 23.419 |
| 2. Interest, foreign exchange differences, dividens and similar income from third parties | 133 | ||||
| 3. Income from investments in associates and joint ventures | 134 | ||||
| 4. Unrealised gains (income) from financial assets | 135 | ||||
| 5. Other financial income | 136 | ||||
| IV. FINANCIAL EXPENSES (138 to 141) | 137 | 848.451 | 848.451 | 1.121.028 | 1.121.028 |
| 1. Interest, foreign exchange differences, dividends and similar income from related parties | 138 | ||||
| 2. Interest, foreign exchange differences, dividends and similar income from third parties | 139 | 848.451 | 848.451 | 1.121.028 | 1.121.028 |
| 3. Unrealised losses (expenses) from financial assets | 140 | ||||
| 4. Other financial expenses | 141 | ||||
| V. SHARE OF PROFIT FROM ASSOCIATED COMPANIES | 142 | ||||
| VI. SHARE OF LOSS FROM ASSOCIATED COMPANIES | 143 | ||||
| VII. EXTRAORDINARY - OTHER INCOME | 144 | ||||
| VIII. EXTRAORDINARY - OTHER EXPENSES | 145 | ||||
| IX. TOTAL INCOME (111+131+142+144) | 146 | 18.296.166 | 18.296.166 | 20.665.792 | 20.665.792 |
| X. TOTAL EXPENSES (114+137+143+145) | 147 | 15.661.633 | 15.661.633 | 17.990.156 | 17.990.156 |
| XI. PROFIT OR LOSS BEFORE TAXES (146-147) | 148 | 2.634.533 | 2.634.533 | 2.675.636 | 2.675.636 |
| 1. Profit before taxes (146-147) | 149 | 2.634.533 | 2.634.533 | 2.675.636 | 2.675.636 |
| 2. Loss before taxes (147-146) | 150 | 0 | 0 | 0 | 0 |
| XII. TAXATION | 151 | ||||
| XIII. PROFIT OR LOSS FOR THE PERIOD (148-151) | 152 | 2.634.533 | 2.634.533 | 2.675.636 | 2.675.636 |
| 1. Profit for the period (149-151) | 153 | 2.634.533 | 2.634.533 | 2.675.636 | 2.675.636 |
| 2. Loss for the period (151-148) | 154 | 0 | 0 | 0 | 0 |
| ADDITION TO PROFIT AND LOSS ACCOUNT (only for consolidated financial statements) | |||||
|---|---|---|---|---|---|
| XIV. PROFIT OR LOSS FOR THE PERIOD | |||||
| 1. Attributable to majority owners | 155 | ||||
| 2. Attributable to minority interest | 156 | ||||
| STATEMENT OF OTHER COMPREHENSIVE INCOME (only for IFRS adopters) | |||||
| I. PROFIT OR LOSS FOR THE PERIOD (=152) | 157 | ||||
| II. OTHER COMPREHENSIVE INCOME/LOSS BEFORE TAXES (159 to 165) | 158 | 0 | 0 | 0 | 0 |
| 1. Exchange differences from international settlement | 159 | ||||
| 2. Changes in revaluation reserves of long-term tangible and intangible assets | 160 | ||||
| 3. Profit or loss from re-evaluation of financial assets held for sale | 161 | ||||
| 4. Profit or loss from cash flow hedging | 162 | ||||
| 5. Profit or loss from hedging of foreign investments | 163 | ||||
| 6. Share of other comprehensive income/loss from associatied companies | 164 | ||||
| 7. Actuarial gains/losses from defined benefit plans | 165 | ||||
| III. TAXATION OF OTHER COMPREHENSIVE INCOME FOR THE PERIOD | 166 | ||||
| IV. NET OTHER COMPREHENSIVE INCOME FOR THE PERIOD (158 - 166) | 167 | 0 | 0 | 0 | 0 |
| V. COMPREHENSIVE INCOME OR LOSS FOR THE PERIOD (157+167) | 168 | 0 | 0 | 0 | 0 |
| ADDITION TO STATEMENT OF OTHER COMPREHENSIVE INCOME (only for consolidated financial statements) | |||||
| VI. COMPREHENSIVE INCOME OR LOSS FOR THE PERIOD | |||||
| 1. Attributable to majority owners | 169 | ||||
| 2. Attributable to minority interest | 170 |
Cash flow statement - indirect method period 01/01/2017 to 31/03/2017
| Company: ILIRIJA d.d. BIOGRAD NA MORU | |||
|---|---|---|---|
| Position | AOP | Previous period |
Current period |
| 1 | 2 | 3 | 4 |
| CASH FLOWS FROM OPERATING ACTIVITIES | |||
| 1. Profit before tax | 001 | 2.634.533 | 2.675.636 |
| 2. Depreciation and amortisation | 002 | 2.056.495 | 2.551.212 |
| 3. Increase of current liabilities | 003 | ||
| 4. Decrease of current receivables | 004 | 2.545.047 | |
| 5. Decrease of inventories | 005 | 332.619 | |
| 6. Other cash flow increases | 006 | 3.895.421 | |
| I. Total increase of cash flow from operating activities | 007 | 11.464.115 | 5.226.848 |
| 1. Decrease of current liabilities | 008 | 10.795.816 | 9.661.705 |
| 2. Increase of current receivables | 009 | 337.537 | |
| 3. Increase of inventories | 010 | 251.258 | |
| 4. Other cash flow decreases | 011 | 312.699 | |
| II. Total decrease of cash flow from operating activities | 012 | 11.108.515 | 10.250.500 |
| A1) NET INCREASE OF CASH FLOW FROM OPERATING ACTIVITIES | 013 | 373.108 | 0 |
| A2) NET DECREASE OF CASH FLOW FROM OPERATING ACTIVITIES | 014 | 0 | 5.023.652 |
| CASH FLOW FROM INVESTING ACTIVITIES | |||
| 1. Proceeds from sale of non-current assets | 015 | ||
| 2. Proceeds from sale of non-current financial assets | 016 | ||
| 3. Interest received | 017 | ||
| 4. Dividend received | 018 | ||
| 5. Other proceeds from investing activities | 019 | 631.925 | 2.599.175 |
| III. Total cash inflows from investing activities | 020 | 631.925 | 2.599.175 |
| 1. Purchase of non-current assets | 021 | 3.933.168 | |
| 2. Purchase of non-current financial assets | 022 | ||
| 3. Other cash outflows from investing activities | 023 | 6.767.385 | |
| IV. Total cash outflows from investing activities | 024 | 6.767.385 | 3.766.832 |
| B1) NET INCREASE OF CASH FLOW FROM INVESTING ACTIVITIES | 025 | 0 | 0 |
| B2) NET DECREASE OF CASH FLOW FROM INVESTING ACTIVITIES | 026 | 6.135.460 | 1.167.657 |
| CASH FLOW FROM FINANCING ACTIVITIES | |||
| 1. Proceeds from issue of equity securities and debt securities | 027 | ||
| 2. Proceeds from loans and borrowings | 028 | 7.283.188 | 8.278.442 |
| 3. Other proceeds from financing activities | 029 | ||
| V. Total cash inflows from financing activities | 030 | 7.283.188 | 8.278.442 |
| 1. Repayment of loans and bonds | 031 | 1.681.020 | 2.616.170 |
| 2. Dividends paid | |||
| 3. Repayment of finance lease | 032 | 736.644 | |
| 4. Purchase of treasury shares | 033 | ||
| 034 | |||
| 5. Other cash outflows from financing activities | 035 | ||
| VI. Total cash outflows from financing activities | 036 | 1.681.020 | 3.352.814 |
| C1) NET INCREASE OF CASH FLOW FROM FINANCING ACTIVITIES | 037 | 5.602.168 | 4.925.628 |
| C2) NET DECREASE OF CASH FLOW FROM FINANCING ACTIVITIES | 038 | 0 | 0 |
| Total increases of cash flows (013-014+025-026+037-038) | 039 | 0 | 0 |
| Total decreases of cash flows (014-013+026-025+038-037) | 040 | 160.184 | 1.265.681 |
| Cash and cash equivalents at the beginning of period | 041 | 337.876 | 2.340.622 |
| Increase of cash and cash equivalents | 042 | ||
| Decrease of cash and cash equivalents | 043 | ||
| Cash and cash equivalents at the end of period | 044 | 177.692 | 1.074.941 |
| STATEMENT OF CHANGES IN EQUITY | |||
|---|---|---|---|
| period 31.3.2017 1.1.2017 to |
|||
| Position | AOP | Previous year |
Current year |
| 1 | 2 | 3 | 4 |
| 1. Subscribed share capital | 001 | 150.857.300 | 174.977.880 |
| 2. Capital reserves | 002 | 8.921.539 | 26.723.874 |
| 3. Reserves from profit | 003 | 21.693.815 | 23.435.964 |
| 4. Retained earnings or loss carried forward | 004 | 34.903.514 | 50.546.190 |
| 5. Net profit or loss for the period | 005 | 2.634.533 | 2.675.636 |
| 6. Revaluation of tangible assets | 006 | ||
| 7. Revaluation of intangible assets | 007 | ||
| 8. Revaluation of available for sale assets | 008 | ||
| 9. Other revaluation | 009 | ||
| 10. Total equity and reserves (AOP 001 to 009) | 010 | 219.010.701 | 278.359.544 |
| 11. Foreign exchenge differences from foreign investments | 011 | ||
| 12. Current and deferred taxes | 012 | ||
| 13. Cash flow hedge | 013 | ||
| 14. Change of accounting policies | 014 | ||
| 15. Correction of significant mistakes pf prior period | 015 | ||
| 16. Other changes | 016 | ||
| 17.Total increase or decrease of equity (AOP 011 to 016) | 017 | 39.729.842 | 59.348.843 |
| 17 a. Attributable to majority owners | 018 | ||
| 17 b. Attributable to minority interest | 019 |
More from Ilirija d.d.
Interim / Quarterly Report
2026
Apr 29
Interim / Quarterly Report
2026
Apr 29
Interim / Quarterly Report
2026
Apr 29
Interim / Quarterly Report
2026
Apr 29
Report Publication Announcement
2026
Apr 29
Report Publication Announcement
2026
Apr 29
Declaration of Voting Results & Voting Rights Announcements
2026
Apr 22
Declaration of Voting Results & Voting Rights Announcements
2026
Apr 22
AGM Information
2026
Feb 26
Proxy Solicitation & Information Statement
2026
Feb 26